Real-World Effectiveness (RWE) of Dupilumab in Reducing Asthma Exacerbations and Use of Inhaled Corticosteroids and Short-Acting β-Agonists

被引:0
|
作者
Pawar, A. [1 ]
Blaiss, M. S. [2 ]
Modena, B. D. [3 ]
Khan, A. H. [4 ]
Gomez, L. De Prado [5 ]
Nag, A. [1 ]
Zhang, Y. [6 ]
Ortiz, B. [6 ]
Jacob-Nara, J. A. [7 ]
机构
[1] Sanofi, Cambridge, MA USA
[2] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[3] Allergy & Rheumatol Med Clin, La Jolla, CA USA
[4] Sanofi, Chilly Mazarin, France
[5] Sanofi, Reading, Berks, England
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Bridgewater, NJ USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5353
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Relationship between inhaled corticosteroids adherence, short-acting beta agonists use, exacerbations and self-reported asthma control
    Vervloet, Marcia
    Weesie, Yvette M.
    Kocks, Janwillem W. H.
    van Dijk, Liset
    Korevaar, Joke C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 300 - 300
  • [2] Real-world Effectiveness of Mepolizumab in Reducing Asthma Exacerbations in Japan
    Nagase, H.
    Tamaoki, J.
    Suzuki, T.
    Nezu, Y.
    Akiyama, S.
    Cole, A.
    Yang, S.
    Mu, G.
    Katsumata, M.
    Komatsubara, M.
    Cristancho, R. Alfonso
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] Dupilumab Real-world Effectiveness (RWE) in Reducing Healthcare Resource Utilization Among Moderate-to-Severe Asthma Patients
    Modena, B. D.
    Pawar, A.
    Blaiss, M. S.
    Khan, A.
    Gomez, L. De Prado
    Zhang, Y.
    Radwan, A.
    Jacob-Nara, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [4] Real-world effectiveness (RWE) of dupilumab in reducing healthcare resource utilization among moderate-to-severe asthma patients
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A. H.
    Gomez, L. De Prado
    Zhang, Y.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Gomez, L. De Prado
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] Real-world Effectiveness of Dupilumab on Oral Corticosteroid Use and Asthma Exacerbations in Patients With Moderate-to-Severe Asthma
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A.
    De Prado Gomez, L.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [6] Usage Patterns of Short-Acting β2-Agonists and Inhaled Corticosteroids in Asthma: A Targeted Literature Review
    Amin, Suvina
    Soliman, Mena
    McIvor, Andrew
    Cave, Andrew
    Cabrera, Claudia
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (08): : 2556 - +
  • [7] Real-world effectiveness of dupilumab on oral corticosteroid use in asthma
    Wark, P.
    Pawar, A.
    Blaiss, M.
    Modena, B.
    Khan, A.
    Gomez, De Prado L.
    Pandit-Abid, N.
    Radwan, A.
    Moody, J.
    Jacob-Nara, J.
    [J]. RESPIROLOGY, 2023, 28 : 87 - 88
  • [8] As-Needed Use of Short-Acting β2-Agonists Alone Versus As-Needed Use of Short-Acting β2-Agonists Plus Inhaled Corticosteroids in Pediatric Patients With Mild Intermittent (Step 1) Asthma: A Cost-Effectiveness Analysis
    Rodriguez-Martinez, Carlos E.
    Sossa-Briceno, Monica P.
    Antonio Buendia, Jefferson
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (06): : 1562 - 1568
  • [9] Regular use of corticosteroids and low use of short-acting β2-agonists can reduce asthma hospitalization
    Senthilselvan, A
    Lawson, JA
    Rennie, DC
    Dosman, JA
    [J]. CHEST, 2005, 127 (04) : 1242 - 1251
  • [10] Electronic medication monitoring versus self-reported use of inhaled corticosteroids and short-acting beta2-agonists in uncontrolled asthma
    Mosnaim, Giselle S.
    Stempel, David A.
    Gonzalez, Candy
    Adams, Brittney
    BenIsrael-Olive, Naomi
    Gondalia, Rahul
    Kaye, Leanne
    Shalowitz, Madeleine
    Szefler, Stanley
    [J]. JOURNAL OF ASTHMA, 2022, 59 (10) : 2024 - 2027